12936_2015_832_MOESM6_ESM.tif (75.69 MB)
MOESM6 of Effect of mushroom Agaricus blazei on immune response and development of experimental cerebral malaria
figure
posted on 2015-08-11, 05:00 authored by Cynthia Val, Fátima Brant, Aline Miranda, Flávia Rodrigues, Bruno Oliveira, Elândia Santos, Diego Assis, Lísia Esper, Bruno Silva, Milene Rachid, Herbert Tanowitz, Antônio Teixeira, Mauro Teixeira, Wiliam Régis, Fabiana MachadoAdditional file 6. Fraction C treated mice did not display clinical signs of CM and significant differences in haematrocrit during P. berghei infection. C57BL/6 mice were treated with fraction C of A. blazei or chloroquine three days before infection, then infected with 105 pRBCs, and treated until 7 dpi. (A) clinical signs of cerebral malaria assessed by the RMCBS score and (B) haematocrit assessed on 5th dpi, normalized relative to that of uninfected controls for each mouse group. RMCBS score and haematocrit values were expressed as mean ± SD of 5 mice per group. ***p < 0.001, ANOVA followed Bonferroni’s test.
